Alan Ka‐Lun Kai
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism 3
-
- Hepatocellular Carcinoma Treatment and Prognosis 1
-
- Angiogenesis and VEGF in Cancer 1
- Wnt/β-catenin signaling in development and cancer 1
- Cancer-related gene regulation 1
-
- Peptidase Inhibition and Analysis 1
-
- Cancer Mechanisms and Therapy 1
-
- Cancer Research and Treatments 1
Alan Ka‐Lun Kai
6 papers receiving 512 citations
Peers
Comparison fields: 5 of 55
- Cancer Research 310
- Hepatology 46
- Molecular Biology 361
- Oncology 125
- Pathology and Forensic Medicine 47
Countries citing papers authored by Alan Ka‐Lun Kai
This map shows the geographic impact of Alan Ka‐Lun Kai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Ka‐Lun Kai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Ka‐Lun Kai more than expected).
Fields of papers citing papers by Alan Ka‐Lun Kai
This network shows the impact of papers produced by Alan Ka‐Lun Kai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Ka‐Lun Kai. The network helps show where Alan Ka‐Lun Kai may publish in the future.
Co-authorship network
The 19 scholars most cited alongside Alan Ka‐Lun Kai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 173 | |
| 2 | 2016 | 103 | |
| 3 | 2016 | 63 | |
| 4 | 2015 | 52 | |
| 5 | 2015 | 53 | |
| 6 | 2013 | 69 |
About Alan Ka‐Lun Kai
Alan Ka‐Lun Kai is a scholar working on Cancer Research, Hepatology and Biotechnology, having authored 6 papers that have together received 513 indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (3 papers), Angiogenesis and VEGF in Cancer (1 paper), Wnt/β-catenin signaling in development and cancer (1 paper), Cancer Research and Treatments (1 paper), Cancer Mechanisms and Therapy (1 paper), Cancer-related gene regulation (1 paper), Peptidase Inhibition and Analysis (1 paper) and Hepatocellular Carcinoma Treatment and Prognosis (1 paper). The work is most often cited by research in Cancer Research (310 citations), Hepatology (46 citations) and Molecular Biology (361 citations). Alan Ka‐Lun Kai has collaborated with scholars based in Hong Kong and China. Frequent co-authors include Irene Oi‐Lin Ng, Carmen Chak‐Lui Wong, Regina Cheuk‐Lam Lo, Daniel Wai‐Hung Ho, Lo‐Kong Chan, Joyce Man‐Fong Lee, Terence K. Lee, Carmen Oi‐Ning Leung, Chun‐Ming Wong and Albert Chan. Their work appears in journals such as Hepatology, Gut and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.